Updated May 2026 · SEC EDGAR data
How Did Edwards Lifesciences (EW) Perform?
Edwards Lifesciences (EW) is currently classified TAILWIND on the EarningsCallAI operator signal, with HIGH confidence, drawn from 8 quarters of SEC EDGAR XBRL filings and earnings call commentary. Latest reported revenue is $1.6B. Revenue grew +19.0% year-over-year. EPS came in at $0.66, with net income of $380.7M. Sector: Healthcare.
Headline Numbers
What the TAILWIND Signal Means
Edwards Lifesciences is currently classified TAILWIND with high confidence. The structured trend across recent quarters shows revenue acceleration; management commentary in the call backs that up with positive demand and pricing language. For operators in adjacent markets, that is a constructive backdrop.
Revenue Trajectory
Edwards Lifesciences grew revenue +19.0% year-over-year, a strong growth rate that meaningfully outpaces nominal GDP. For an S&P 500 company, sustaining that rate quarter after quarter is typically the mark of a category leader or a durable secular tailwind.
Net income of $380.7M on $1.6B of revenue works out to a 23.1 percent net margin, exceptionally strong profitability. Margins this high typically reflect software-style scale economics, a dominant market position, or a particularly favorable product mix.
Quarterly Profile
| Metric | Value |
|---|---|
| Operator Signal | TAILWIND |
| Signal Confidence | HIGH |
| Sector | Healthcare |
| Quarters Tracked | 8 |
How the Signal Is Calculated
The EarningsCallAI operator signal blends a quantitative read of revenue trajectory across the most recent four to eight quarters with a qualitative read of management commentary in the earnings call. Both inputs come from primary public sources: SEC EDGAR XBRL filings for structured financials, and SEC Form 8-K earnings releases for management commentary. Where the two inputs agree, signal confidence is HIGH; where they conflict, confidence drops. Read the full methodology for the formal classification rules.
Frequently Asked Questions
How did Edwards Lifesciences perform in its latest earnings report?
Edwards Lifesciences reported $1.6B in revenue and $0.66 EPS in the most recent quarter filed on SEC EDGAR. Year-over-year revenue growth was +19.0%. The current operator signal is TAILWIND with HIGH confidence.
What does Edwards Lifesciences's TAILWIND signal mean?
TAILWIND means revenue is accelerating across recent quarters and management commentary is positive on demand. For operators in adjacent markets, the read is constructive: budgets in this space are likely healthy.
Where does Edwards Lifesciences's data come from?
All structured financials, revenue, EPS, net income, growth rates, are pulled directly from Edwards Lifesciences's SEC EDGAR XBRL filings (10-K, 10-Q). Operator signal classification is EarningsCallAI methodology, applied consistently across all S&P 500 companies and updated each earnings season. EDGAR data is in the public domain.
What sector is Edwards Lifesciences in?
Edwards Lifesciences is classified in the Healthcare sector. The classification follows standard S&P 500 sector taxonomy. To see how Edwards Lifesciences compares to other companies in the same sector, browse the sector page or use the side-by-side comparison tool.
Is the TAILWIND signal investment advice?
No. The operator signal is built for business operators evaluating market demand and competitive trends, not for stock trading decisions. A TAILWIND signal does not mean buy the stock; a HEADWIND signal does not mean sell. Always consult a licensed financial advisor before making investment decisions.
Edwards Lifesciences (EW) is currently classified TAILWIND on the EarningsCallAI operator signal, with HIGH confidence, drawn from 8 quarters of SEC EDGAR XBRL filings and earnings call commentary. Latest reported revenue is $1.6B. Revenue grew +19.0% year-over-year. EPS came in at $0.66, with net income of $380.7M. Sector: Healthcare.